7 Fun Facts About the Dow Jones Industrial Average
Madeleine Johnson - Zacks Investment Research - Mon Nov 16, 5:48PM CST
Read on for an in-depth look at 7 fun facts about one of the most important financial indices in the U.S. economy.
GE: 30.12 (-0.24), GS: 191.72 (-0.44), DD: 66.83 (-0.41), CSCO: 27.00 (+0.21)
Trian Ups GE Stake By 83%, Looks For Bigger Payouts
at Investor's Business Daily - Mon Nov 16, 3:44PM CST
Hedge fund Trian Fund Management is looking for bigger payouts from General Electric (GE) as it raised its stake in the industrial conglomerate. Nelson Peltz's Trian raised its stake in GE by 83%. Trian had said earlier it raised its holdings in the...
GE: 30.12 (-0.24), MDLZ: 43.92 (-0.14), DD: 66.83 (-0.41), PEP: 99.06 (-0.50)
DuPont, Entomol Ink License Pact for HCO Insect Repellent
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 12:00PM CST
DuPont (DD) signed a commercial license agreement with Entomol Products, LLC, granting the latter the right to make and sell products using DuPont's HCO technology.
CE: 71.66 (+0.11), IOSP: 56.80 (-0.09), DD: 66.83 (-0.41)
EI Du Pont de Nemours Rises 1.42% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Nov 13, 4:43PM CST
EI Du Pont de Nemours (NYSE
DD: 66.83 (-0.41)
SmarTrend Watching for Potential Pullback in Shares of EI Du Pont de Nemours After 1.42% Gain
Comtex SmarTrend(R) - Fri Nov 13, 4:42PM CST
EI Du Pont de Nemours (NYSE
DD: 66.83 (-0.41)
Dow 30 Stock Roundup: Cisco Beats, DuPont to Buy Enzyme and Tech Assets from Dyadic
Swarup Gupta - Zacks Investment Research - Fri Nov 13, 2:14PM CST
Concerns over a rate hike in December, weak data from China and the oil price slump led to a disappointing week for the Dow.
DHI: 31.55 (+0.16), GS: 191.72 (-0.44), JPM: 66.28 (-0.23), UTX: 97.65 (-0.18), XOM: 80.36 (-0.54), MCD: 111.19 (+0.13), M: 37.89 (-0.73), DD: 66.83 (-0.41), MSFT: 53.15 (-0.61), BA: 146.07 (+1.65), CVX: 91.29 (-0.16), AAPL: 114.09 (-0.09), CSCO: 27.00 (+0.21)
Stock Market News for November 13, 2015
Zacks Equity Research - Zacks Investment Research - Fri Nov 13, 9:10AM CST
Slide in prices of commodities including oil and copper dragged down energy and materials shares, which in turn pushed major benchmarks into negative territory on Thursday
KMI: 23.27 (-0.76), KSS: 44.39 (+0.45), AA: 8.29 (unch), LYB: 94.81 (+0.39), AAP: 163.69 (-0.53), FCX: 8.37 (-0.49), DD: 66.83 (-0.41), COP: 54.01 (-0.36), XOM: 80.36 (-0.54), WMB: 37.41 (+0.10), CVX: 91.29 (-0.16), DOW: 51.77 (+0.12)
DuPont Named 2015 Thomson Reuters Top 100 Global Innovator
GlobeNewswire - Fri Nov 13, 9:02AM CST
via PRWEB - Thomson Reuters has named DuPont a 2015 Top Global Innovator, marking the fifth consecutive year the company has been named to the prestigious list. The program honors corporations and institutions around the world that are at the heart of innovation - creating new technologies and bringing them to life through commercialization.
DD: 66.83 (-0.41)
DuPont Digital Printing & EFI Reggiani Launch Pigment Ink
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 1:35PM CST
DuPont's (DD) Digital Printing business has collaborated with EFI Reggiani to introduce the DuPont Artistri PK2600 digital textile pigment ink.
CE: 71.66 (+0.11), IOSP: 56.80 (-0.09), DD: 66.83 (-0.41)
DuPont's Unit to Buy Biotechnology Assets from Dyadic
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 11:20AM CST
DuPont's (DD) Industrial Biosciences unit has agreed to buy enzyme and technology assets from biotech company Dyadic International, Inc.
MBII: 2.20 (-0.05), CE: 71.66 (+0.11), IOSP: 56.80 (-0.09), DD: 66.83 (-0.41)
E. I. du Pont de Nemours (DD) is in Overbought Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 7:43AM CST
E. I. du Pont de Nemours and Company (DD) has moved higher as of late, but there could definitely be trouble on the horizon for this company
DD: 66.83 (-0.41)
18.9% Return Seen to Date on SmarTrend EI Du Pont de Nemours Call (DD)
Comtex SmarTrend(R) - Wed Nov 11, 7:10PM CST
SmarTrend identified an Uptrend for EI Du Pont de Nemours (NYSE
DD: 66.83 (-0.41)
DuPont Names Edward Breen Permanent Chairman and CEO
Zacks Equity Research - Zacks Investment Research - Wed Nov 11, 2:45PM CST
DuPont (DD) has appointed Edward D. Breen as its chairman and CEO, effective immediately.
TYC: 35.52 (-0.19), SYT: 76.96 (+4.59), DD: 66.83 (-0.41), DOW: 51.77 (+0.12)
5 Blue-Chip High-Dividend Stocks for 2016 That Meet Warren Buffett's Standards
at The Street - Wed Nov 11, 10:24AM CST
By using the same criteria that Warren Buffett used to become a billionaire, we've pinpointed stocks that could make you rich over time.
MMM: 157.56 (-0.65), F: 14.18 (+0.14), GE: 30.12 (-0.24), DD: 66.83 (-0.41), BA: 146.07 (+1.65)
EI Du Pont de Nemours (DD) Breaks Through Support at $66.08
Comtex SmarTrend(R) - Tue Nov 10, 9:38AM CST
Shares of EI Du Pont de Nemours (NYSE
DD: 66.83 (-0.41)
Company News for November 10, 2015
Zacks Equity Research - Zacks Investment Research - Tue Nov 10, 9:10AM CST
Companies in the News are: PCL,WY,DISH,DD,HTZ
HTZ: 16.32 (+0.95), DD: 66.83 (-0.41), WY: 30.91 (+0.77), PCL: 48.60 (+1.48), DISH: 62.18 (-0.27)
DuPont Digital Printing Collaborates With EFI Reggiani to Deliver New Digital Textile Pigment Ink
GlobeNewswire - Tue Nov 10, 8:25AM CST
DuPont Digital Printing (DuPont) and EFI Reggiani (Reggiani) are pleased to announce the introduction of DuPont(TM) Artistri(R) PK2600 digital textile pigment ink for EFI(TM) Reggiani ReNOIR digital textile printers. Artistri(R) PK2600 ink was developed by DuPont for EFI Reggiani and is designed primarily for cotton textile roll-to-roll printing that shows performance comparable to reactive ink results.
EFII: 47.96 (+0.08), DD: 66.83 (-0.41)
DuPont Industrial Biosciences to Acquire Biotechnology Assets from Dyadic
PRWeb - Tue Nov 10, 7:09AM CST
DuPont Industrial Biosciences (DuPont) has signed an agreement to purchase enzyme and technology assets from Dyadic International, Inc., including Dyadic's C1 platform, a fungal expression technology for producing enzymes. The transaction will further extend the world-leading biotechnology capabilities of DuPont's Industrial Biosciences business.
DD: 66.83 (-0.41)